Evidence map›Paper›PMID 33191679›Full record

ArticleAllergy, asthma & immunology research2021

The Role of Macrophage Migration Inhibitory Factor (MIF) in Asthmatic Airway Remodeling.

Ruyi Li, Feiyun Wang, Jianghong Wei, Yun Lin, Guofang Tang, Lizong Rao, Libing Ma, Qing Xu, Jingjie Wu, Qian Lv and 8 more

Open access · diamondAbstract read
In one paragraph

Article in Allergy, asthma & immunology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Ruyi LiDepartment of Respiratory and Critical Care Medicine, Key Laboratory of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, China.ORCID https://orcid.org/0000-0002-8261-2128
Feiyun WangInnovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Jianghong WeiDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China.
Yun LinDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.
Guofang TangDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China.
Lizong RaoLaboratory of Pulmonary Diseases, Guilin Medical University, Guilin, China.
Libing MaDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China.
Qing XuDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China.
Jingjie WuDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China.
Qian LvDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China.
Rui ZhouDepartment of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Changsha, China.
Huiren LeiLaboratory of Pulmonary Diseases, Guilin Medical University, Guilin, China.
Xueqiang ZhaoDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.
Dong YaoLaboratory of Pulmonary Diseases, Guilin Medical University, Guilin, China.
Bo XiaoLaboratory of Pulmonary Diseases, Guilin Medical University, Guilin, China.
Haiming HuangLaboratory of Pulmonary Diseases, Guilin Medical University, Guilin, China.
Jiange ZhangInnovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. jgzhang@shutcm.edu.cn.
Biwen MoDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, China. mobiwen2002@sohu.com.
Guilin Medical University · CNCentral South University · CNShanghai University of Traditional Chinese Medicine · CN

Funding

High Level of Innovation Team and Outstanding Scholars Program in Colleges and Universities in GuangxiNational Natural Science Foundation of China 81460005National Natural Science Foundation of China 81760008National Natural Science Foundation of China 81960007Natural Science Foundation of Guangxi Province 2015GXNSFAA139107New Interdisciplinary Subject Funding Program for Shanghai Traditional Chinese Medicine E2-F18003Science and Technology Commission of Shanghai Municipality 18401933500Shanghai Municipal Education Commission 2019-01-07-00-10-E00072
6 · The paper itself

Abstract

purposeRecent studies have demonstrated that macrophage migration inhibitory factor (MIF) is of importance in asthmatic inflammation. The role of MIF in modulating airway remodeling has not yet been thoroughly elucidated to date. In the present study, we hypothesized that MIF promoted airway remodeling by intensifying airway smooth muscle cell (ASMC) autophagy and explored the specific mechanisms.

methodsMIF knockdown in the lung tissues of C57BL/6 mice was conducted by instilling intratracheally adeno-associated virus (AAV) vectors (MIF-mutant AAV9) into mouse lung tissues. Mice genetically deficient in the autophagy marker ATG5 (ATG5

resultsFirst, MIF knockdown in the lung tissues of mice showed markedly reduced airway remodeling in OVA murine mice models. Secondly, ASMC autophagy was increased in the OVA-challenged models. Mice genetically deficient in the autophagy marker ATG5 (ATG5

conclusionsMIF can increase asthmatic airway remodeling by enhancing ASMC autophagy. Macrophage-derived MIF can promote ASMC autophagy by targeting CD74.

Indexed as

airway remodelingautophagyMacrophage migration inhibitory factorSmooth muscle

Identifiers

PMID33191679
PMCPMC7680835
OpenAlexW3081406669

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.